Docetaxel and Oxaliplatin in the Second-Line Treatment of Platinum-Sensitive Recurrent Ovarian Cancer: A Phase II Study

    August 2007 in “ Annals of Oncology ”
    Gabriella Ferrandina, M. Ludovisi, Rosa De Vincenzo … Maria Rosaria Valerio
    Studysummary Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on annalsofoncology.org →
    Discuss this study in the Community →